Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bloembergen, W. E.
Right arrow Articles by Wolfe, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bloembergen, W. E.
Right arrow Articles by Wolfe, R. A.

Journal of the American Society of Nephrology, Vol 6, 177-183, Copyright © 1995 by American Society of Nephrology


REGULAR ARTICLES

A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis

WE Bloembergen, FK Port, EA Mauger and RA Wolfe
Department of Internal Medicine, School of Medicine, University of Michigan, Ann Arbor, USA.

Patients with ESRD treated with dialysis have a high mortality rate. Controversy exists as to whether this high mortality rate is affected by modality choice. The purpose of this epidemiologic study was to compare mortality in prevalent hemodialysis-treated (HD) and peritoneal dialysis-treated (PD) patients in a large national sample, adjusting for demographic characteristics. Data were obtained from the U.S. Renal Data System for patients prevalent on January 1 of the years 1987, 1988, and 1989, each with 1 yr of follow-up. Patients were censored at transplantation. Death rates per 100 patient years were compared between HD and PD, adjusting for age, race, gender, cause of ESRD (diabetes versus nondiabetes) and < 1 yr or > 1 yr of prior ESRD, by the use of Poisson regression. There were 42,372 deaths occurring over 170,700 patient years at risk. On average, prevalent patients treated with PD had a 19% higher adjusted mortality risk (relative risk (RR) = 1.19; P < 0.001) than did those treated with HD. This risk was found to be insignificant (P > 0.05) and small for ages < 55 and increasingly large and significant for ages > 55 yr. It was accentuated in diabetics (RR = 1.38; P < 0.001) but was also present in nondiabetics (RR = 1.11; P < 0.001). Although present in both males and females, this risk was accentuated in females (RR = 1.30 versus 1.11; both P < 0.001). In this national study of prevalent U.S. dialysis patients, treatment assignment to PD was associated with a 19% higher all-cause mortality rate than HD.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
P. M. Just, F. Th. de Charro, E. A. Tschosik, L. L. Noe, S. K. Bhattacharyya, and M. C. Riella
Reimbursement and economic factors influencing dialysis modality choice around the world
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2365 - 2373.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
O. Khawar, K. Kalantar-Zadeh, W. K. Lo, D. Johnson, and R. Mehrotra
Is the Declining Use of Long-Term Peritoneal Dialysis Justified by Outcome Data?
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1317 - 1328.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H. de Jonge, B. Bammens, W. Lemahieu, B. D. Maes, and Y. Vanrenterghem
Comparison of peritoneal dialysis and haemodialysis after renal transplant failure
Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1669 - 1674.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
B. G. Jaar, J. Coresh, L. C. Plantinga, N. E. Fink, M. J. Klag, A. S. Levey, N. W. Levin, J. H. Sadler, A. Kliger, and N. R. Powe
Comparing the Risk for Death with Peritoneal Dialysis and Hemodialysis in a National Cohort of Patients with Chronic Kidney Disease
Ann Intern Med, August 2, 2005; 143(3): 174 - 183.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
G. Schulman
Mortality and Treatment Modality of End-Stage Renal Disease
Ann Intern Med, August 2, 2005; 143(3): 229 - 231.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Termorshuizen, J. C. Korevaar, F. W. Dekker, J. G. van Manen, E. W. Boeschoten, and R. T. Krediet
Hemodialysis and Peritoneal Dialysis: Comparison of Adjusted Mortality Rates According to the Duration of Dialysis: Analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2
J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2851 - 2860.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. C. Winkelmayer, R. J. Glynn, M. A. Mittleman, R. Levin, J. S. Pliskin, and J. Avorn
Comparing Mortality of Elderly Patients on Hemodialysis versus Peritoneal Dialysis: A Propensity Score Approach
J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2353 - 2362.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. G. Kutner, R. Zhang, W. M. McClellan, and S. A. Cole
Psychosocial predictors of non-compliance in haemodialysis and peritoneal dialysis patients
Nephrol. Dial. Transplant., January 1, 2002; 17(1): 93 - 99.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. G. Heaf, H. Lokkegaard, and M. Madsen
Initial survival advantage of peritoneal dialysis relative to haemodialysis
Nephrol. Dial. Transplant., January 1, 2002; 17(1): 112 - 117.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Keshaviah, A. J. Collins, J. Z. Ma, D. N. Churchill, and K. E. Thorpe
Survival Comparison between Hemodialysis and Peritoneal Dialysis Based on Matched Doses of Delivered Therapy
J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S48 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Gokal
Peritoneal Dialysis in the 21st Century: An Analysis of Current Problems and Future Developments
J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S104 - 115.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. M. MOIST, F. K. PORT, S. M. ORZOL, E. W. YOUNG, T. OSTBYE, R. A. WOLFE, T. HULBERT-SHEARON, C. A. JONES, and W. E. BLOEMBERGEN
Predictors of Loss of Residual Renal Function among New Dialysis Patients
J. Am. Soc. Nephrol., March 1, 2000; 11(3): 556 - 564.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. VAN BIESEN, R. C. VANHOLDER, N. VEYS, A. DHONDT, and N. H. LAMEIRE
An Evaluation of an Integrative Care Approach for End-Stage Renal Disease Patients
J. Am. Soc. Nephrol., January 1, 2000; 11(1): 116 - 125.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
D. E. SCHAUBEL and S. S. A. FENTON
Trends in Mortality on Peritoneal Dialysis: Canada,1981-1997
J. Am. Soc. Nephrol., January 1, 2000; 11(1): 126 - 133.
[Abstract] [Full Text]


Home page
Nephrol Dial TransplantHome page
C.-G. Elinder, E. Jones, J. D. Briggs, O. Mehls, S. Mendel, G. Piccoli, S. P. A. Rigden, J. P. d. Santos, K. Simpson, D. Tsakiris, et al.
Improved survival in renal replacement therapy in Europe between 1975 and 1992 : An ERA-EDTA Registry study
Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2351 - 2356.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. ANDO, T. SANAKA, and H. NIHEI
Eicosapentanoic Acid Reduces Plasma Levels of Remnant Lipoproteins and Prevents in Vivo Peroxidation of LDL in Dialysis Patients
J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2177 - 2184.
[Abstract] [Full Text]


Home page
Med Decis MakingHome page
E. B. Bass, M. W. Jenckes, N. E. Fink, K. A. Cagney, A. W. Wu, J. H. Sadler, K. B. Meyer, Andrews. Levey, and N. R. Powe
Use of Focus Groups to Identify Concerns about Dialysis
Med Decis Making, August 1, 1999; 19(3): 287 - 295.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. F. VONESH and J. MORAN
Mortality in End-Stage Renal Disease: A Reassessment of Differencesbetween Patients Treated with Hemodialysis and Peritoneal Dialysis
J. Am. Soc. Nephrol., February 1, 1999; 10(2): 354 - 365.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
R. A. WARD and M. E. BRIER
Retrospective Analyses of Large Medical Databases: What Do They TellUs?
J. Am. Soc. Nephrol., February 1, 1999; 10(2): 429 - 432.
[Full Text]


Home page
NEJMHome page
S. Pastan and J. Bailey
Dialysis Therapy
N. Engl. J. Med., May 14, 1998; 338(20): 1428 - 1437.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP